Abstract
The activation of the complement system may be involved in the pathology of stroke and type 2 diabetes (T2DM). We therefore evaluated the long-term prognostic value of early measurement of serum mannose-binding lectin (MBL) levels, an activator of the complement system, in Chinese T2DM with acute ischemic stroke (AIS). Serum MBL levels were determined in T2DM patients with AIS (N = 188). The adjudicated end points were 1-year functional outcomes and mortality. The prognostic value of MBL was compared with the National Institutes of Health Stroke Scale score and with other known outcome predictors. Patients with an unfavorable outcomes and nonsurvivors had significantly increased MBL levels on admission (P < 0.0001 and P < 0.0001). Multivariate logistic regression analysis adjusted for common risk factors showed that MBL was an independent predictor of functional outcome (odds ratio (OR) = 8.99, 95 % CI 2.21–30.12) and mortality (OR = 13.22, 95 % CI 2.05–41.21). The area under the receiver operating characteristic curve of MBL was 0.75 (95 % CI 0.68–0.83) for functional outcome and 0.85 (95 % CI 0.80–0.90) for mortality. In type 2 diabetic patients with stroke, high levels of MBL predict future functional outcomes and mortality. This indicated that the elevated MBL levels may play a significant role in the pathology of the subsequent damage and that the pathways leading to complement activation warrant further exploration as potential therapeutic targets to improve the prognosis for these patients.
Similar content being viewed by others
References
Yang W, Lu J, Weng J et al (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362:1090–1101
Cheng SY, Zhao YD, Li J et al (2014) Plasma levels of glutamate during stroke is associated with development of post-stroke depression. Psychoneuroendocrinology 47:126–135
Turner MW (2003) The role of mannose-binding lectin in health and disease. Mol Immunol 40:423–429
Fuchs A, Lin TY, Beasley DW et al (2010) Direct complement restriction of flavivirus infection requires glycan recognition by mannose-binding lectin. Cell Host Microbe 8:186–195
Fujita T (2002) Evolution of the lectin-complement pathway and its role in innate immunity. Nat Rev Immunol 2:346–353
Koch A, Melbye M, Sørensen P et al (2001) Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA 285:1316–1321
Ohlenschlaeger T, Garred P, Madsen HO, Jacobsen S (2004) Mannose-binding lectinvariant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med 351:260–267
Hansen TK, Tarnow L, Thiel S et al (2004) Association between mannose-binding lectin and vascular complications in type 1 diabetes. Diabetes 53:1570–1576
Keller TT, van Leuven SI, Meuwese MC et al (2006) Serum levels of mannose-binding lectin and the risk of future coronary artery disease in apparently healthy men and women. Arterioscler Thromb Vasc Biol 26:2345–2350
Rugonfalvi-Kiss S, Dósa E, Madsen HO et al (2005) High rate of early restenosis after carotid eversion endarterectomy in homozygous carriers of the normal mannose-binding lectin genotype. Stroke 36:944–948
Pesonen E, Hallman M, Sarna S et al (2009) Mannose-binding lectin as a risk factor for acute coronary syndromes. Ann Med 41:591–598
Wang ZY, Sun ZR, Zhang LM (2014) The relationship between serum mannose-binding lectin levels and acute ischemic stroke risk. Neurochem Res 39:248–253
Frauenknecht V, Thiel S, Storm L et al (2013) Plasma levels of mannan‐binding lectin (MBL)‐associated serine proteases (MASPs) and MBL‐associated protein in cardio‐and cerebrovascular diseases. Clin Exp Immunol 173:112–120
Zhang NN, Ma AX, Cheng P et al (2011) Association between mannose-binding-lectin gene and type 2 diabetic patients in Chinese population living in the northern areas of China. Zhonghua Liu Xing Bing Xue Za Zhi 32:930–935
Elawa G, AoudAllah AM, Hasaneen AE, El-Hammady AM (2011) The predictive value of serum mannan-binding lectin levels for diabetic control and renal complications in type 2 diabetic patients. Saudi Med J 32:784–790
Siezenga MA, Shaw PK, Daha MR, Rabelink TJ, Berger SP (2011) Low mannose-binding lectin (MBL) genotype is associated with future cardiovascular events in type 2 diabetic South Asians. A prospective cohort study. Cardiovasc Diabetol 10:60
Garred P, Madsen HO, Marquart H et al (2000) Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. J Rheumatol 27:26–34
Ip WK, Lau Y-L, Chan SY et al (2000) Mannose-binding lectin and rheumatoid arthritis in southern Chinese. Arthritis Rheum 43:1679–1687
Brott T, Adams HP Jr, Olinger CP et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20:864–870
Adams HP, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41
Bamford J, Sandercock P, Dennis M et al (1991) Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337:1521–1526
Sims JR, Gharai LR, Schaefer PW (2009) ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 72:2104–2110
Bonita RBR (1988) Modification of Rankin Scale: recovery of motor function after stroke. Stroke 19:1497–1500
Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G (2003) Intensive insulin therapy exerts anti inflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 88:1082–1088
Zhang ZG, Wang C, Wang J, Zhang Z, Yang YL, Gao L, Zhang XY, Chang T, Gao GD, Li LH (2014) Prognostic value of mannose-binding lectin: 90-day outcome in patients with acute ischemic stroke. Mol Neurobiol. doi:10.1007/s12035-014-8682-0
Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27(157–172):207–212
Hovind P, Hansen TK, Tarnow L, Thiel S, Steffensen R, Flyvbjerg A, Parving HH (2005) Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study. Diabetes 54:1523–1527
Sone H, Tanaka S, Suzuki S et al (2013) Leisure-time physical activity is a significant predictor of stroke and total mortality in Japanese patients with type 2 diabetes: analysis from the Japan Diabetes Complications Study (JDCS). Diabetologia 56:1021–1030
Tsutsumi A, Ikegami H, Takahashi R et al (2003) Mannose binding lectin gene polymorphism in patients with type I diabetes. Hum Immunol 64:621–624
Hansen TK, Gall MA, Tarnow L, Thiel S, Stehouwer CD, Schalkwijk CG, Parving HH, Flyvbjerg A (2006) Mannose-binding lectin and mortality in type 2 diabetes. Arch Intern Med 166:2007–2013
Mellbin LG, Bjerre M, Thiel S, Hansen TK (2012) Complement activation and prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. Diabetes Care 35:911–917
Saraheimo M, Forsblom C, Hansen TK et al (2005) On behalf of the FinnDiane study group: increased levels of mannan-bindinglectin (MBL) in type 1 diabetic patients with incipient and overt nephropathy. Diabetologia 48:198–202
Suankratay C, Mold C, Zhang Y, Potempa LA, Lint TF, Gewurz H (1998) Complement regulation in innate immunity and the acute-phase response: inhibition of mannan-binding lectin-initiated complement cytolysis by C-reactive protein (CRP). Clin Exp Immunol 113:353–359
Hansen TK, Forsblom C, Saraheimo M et al (2010) Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes. Diabetologia 53:1517–1524
Collard CD, Vakeva A, Morrissey MA, Agah A, Rollins SA, Reenstra WR, Buras JA, Meri S, Stahl GL (2000) Complement activation after oxidative stress: role of the lectin complement pathway. Am J Pathol 156:1549–1556
Fiane AE, Videm V, Lingaas PS, Heggelund L, Nielsen EW, Geiran OR, Fung M, Mollnes TE (2003) Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair. Circulation 108:849–856
Jack DL, Read RC, Tenner AJ, Frosch M, Turner MW, Klein NJ (2001) Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseriameningitidis serogroup B. J Infect Dis 184:1152–1162
Jordan JE, Montalto MC, Stahl GL (2001) Inhibition of mannose-binding lectin reduces post-ischemic myocardial reperfusion injury. Circulation 104:1413–1418
Granger CB, Mahaffey KW, Weaver WD et al (2003) Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the Complement Inhibition in Myocardial Infarction Treated with Angioplasty(COMMA) trial. Circulation 108:1184–1190
Summerfield JA, Sumiya M, Levin M, Turner MW (1997) Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ 314:1229–1232
Hart ML, Ceonzo KA, Shaffer LA et al (2005) Gastrointestinal ischemia–reperfusion injury in lectin complement pathway dependent without involving C1q. J Immunol 174:6373–6380
Chan RK, Ibrahim SI, Takahashi K et al (2006) The differing roles of the classical and mannose-binding lectin complement pathways in the events following skeletal muscle ischemia–reperfusion. J Immunol 177:8080–8085
Fortpied J, Vertommen D, Van Schaftingen E (2010) Binding of mannose-binding lectin to fructosamines: a potential link between hyperglycaemia and complement activation in diabetes. Diabetes Metab Res Rev 26:254–260
La Bonte LR, Pavlov VI, Tan YS et al (2012) Mannose-binding lectin-associated serine protease-1 is a significant contributor to coagulation in a murine model of occlusive thrombosis. J Immunol 188:885–891
Acknowledgments
We are grateful to the Department of Neurology and Emergency; the nurses, physicians, and patients who participated in our study; and the staff of the central laboratory of the hospital. Authors also acknowledge the contribution of the editors and reviewers who have helped us to improve the manuscript.
Conflict of Interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Fang-Yu Song and Meng-Hai Wucontributed equally to this study.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
ESM 1
(DOCX 17 kb)
Rights and permissions
About this article
Cite this article
Song, FY., Wu, MH., Zhu, Lh. et al. Elevated Serum Mannose-Binding Lectin Levels Are Associated with Poor Outcome After Acute Ischemic Stroke in Patients with Type 2 Diabetes. Mol Neurobiol 52, 1330–1340 (2015). https://doi.org/10.1007/s12035-014-8941-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-014-8941-0